ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates March 18, 2015 Secondary Offering by Valeant Pharmaceuticals International, Inc. on Behalf of Fund Managers, Institutional and Large Investors Who Purchased Shares

NEW ORLEANS--(BUSINESS WIRE)--

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., encourages fund managers and institutional and large individual investors who purchased shares of Valeant Pharmaceuticals International, Inc. VRX in the March 18, 2015 Secondary Offering at $199.00 per share to contact KSF to discuss your legal rights.

What You May Do

If you purchased shares of Valeant or are a fund manager, institutional or large individual investor, and would like to discuss your legal rights and your right to recover for your economic loss, including through a possible private action against Valeant, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com).

About the Lawsuit

On October 14, 2015, Valeant reported that it was subpoenaed by U.S. prosecutors regarding its pricing decisions, drug distribution and patient assistance programs. On October 21, 2015, Citron Research published a report alleging that Valeant is using pharmacies related to Philidor to store inventory and record the transactions as sales and has "created an entire network of phantom captive pharmacies" to create fake sales of drugs or to avoid scrutiny from auditors. On February 22, 2016, Valeant announced that it would restate its 2014 and 2015 financial results. On February 29, 2016, Valeant disclosed that the SEC is investigating the Company. Then, on March 15, 2016, Valeant cut its 2016 revenue forecast and disclosed that its delay in filing an annual report could mean a default on its $30 million debt.

Following this news, the value of Valeant's shares has plummeted.

About Kahn Swick & Foti, LLC

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160321006419/en/